Medical treatment of primary ovarian cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F16%3A10324164" target="_blank" >RIV/00064203:_____/16:10324164 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/16:10324164
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Medical treatment of primary ovarian cancer
Original language description
AGO-OVAR-12, a double-blind phase III trial randomised 1366 patients (2:1) with FIGO stage IIB-IV ovarian cancer (OC) to either to receive six cycles of carboplatin and paclitaxel with nintedanib or placebo after upfront debulking surgery.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FK - Gynaecology and obstetrics
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Gynecological Cancer
ISSN
1048-891X
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
Supplement 1
Country of publishing house
US - UNITED STATES
Number of pages
3
Pages from-to
9-11
UT code for WoS article
000377146400003
EID of the result in the Scopus database
—